Elefante Mark B’s Merck MRK Stock Holding History

Elefante Mark B’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$617K	Hold	4,800	–	–	0.27%	42
2026 Q1	$577K	Hold	4,800	–	–	0.32%	45
2025 Q4	$505K	Hold	4,800	–	–	0.31%	43
2025 Q3	$403K	Sell	4,800 -193	-4%	-$15.9K	0.26%	48
2025 Q2	$395K	Hold	4,993	–	–	0.3%	45
2025 Q1	$448K	Buy	4,993 +1,600	+47%	+$149K	0.36%	43
2024 Q4	$338K	Buy	+3,393	New	+$350K	0.31%	42

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Elefante Mark B's MRK Position: Q2 2026 in Review

Elefante Mark B held its Merck (MRK) position steady in Q2 2026 at 4,800 shares worth $617K. The position accounts for 0.27% of the portfolio, ranked #42.

Elefante Mark B first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Elefante Mark B held 4,800 shares of Merck worth $617K as of Q2 2026.
Elefante Mark B left its Merck share count unchanged in Q2 2026.
Merck made up 0.27% of Elefante Mark B's portfolio in Q2 2026, its #42 holding.
Elefante Mark B first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elefante Mark B's 13F filing for Q2 2026, filed 13 Aug 2026.